Literature DB >> 18771643

Attitudes of men in an Australian male tolerance study towards microbicide use.

Wendy R Holmes1, Lisa Maher, Susan L Rosenthal.   

Abstract

BACKGROUND: Vaginal microbicides are in development to provide new options for the prevention of sexually transmissible infections. Although promoted as a female-initiated product, men may influence the decision to use a microbicide and the way that it is used, so it is important to explore their views.
METHODS: Men (n = 36) enrolled in a 7-day, phase 1 clinical safety trial of SPL7013 Gel were interviewed pre- and post-use of the gel. The trial did not include use of the gel during sex. Interviews were digitally-recorded and transcribed verbatim, and analysed using a framework approach.
RESULTS: The men (mean age 37 years) were interested in the idea of vaginal microbicides, had little knowledge about them, and varied beliefs about how they work. They tended to assess microbicide use in relation to condoms and lubricants. Many would want a microbicide to be as effective as condoms. Participants did not anticipate difficulties discussing use with their partners. Many thought that a microbicide would be less intrusive than condoms; some anticipated that the lubricating properties might enhance sexual pleasure. Some anticipated using a microbicide with a condom or with a lubricant, and a few raised questions about the timing of use and use during different types of sexual activity.
CONCLUSIONS: No major barriers to microbicide use were found in this sample of Australian men, who anticipated being willing to use them if they are shown to be safe and effective. Our findings should help to inform the design of further studies as well as future information materials and anticipatory guidance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18771643      PMCID: PMC3777800          DOI: 10.1071/sh07093

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  34 in total

Review 1.  Heterosexual anal intercourse: prevalence, cultural factors, and HIV infection and other health risks, Part I.

Authors:  D T Halperin
Journal:  AIDS Patient Care STDS       Date:  1999-12       Impact factor: 5.078

2.  Factors affecting men's liking of condoms they have used.

Authors:  A M Smith; D Jolley; J Hocking; K Benton; J Gerofi
Journal:  Int J STD AIDS       Date:  1999-04       Impact factor: 1.359

3.  Men's attitudes towards a potential vaginal microbicide in Zimbabwe, Mexico and the USA.

Authors:  C Coggins; K Blanchard; B Friedland
Journal:  Reprod Health Matters       Date:  2000-05

4.  A randomized controlled trial of the safety of candidate microbicide SPL7013 gel when applied to the penis.

Authors:  Marcus Y Chen; Iona Y Millwood; Handan Wand; Mary Poynten; Matthew Law; John M Kaldor; Steve Wesselingh; Clare F Price; Laura J Clark; Jeremy R A Paull; Christopher K Fairley
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-01       Impact factor: 3.731

5.  Delayed application of condoms, withdrawal and negotiation of safer sex among heterosexual young adults.

Authors:  R De Visser
Journal:  AIDS Care       Date:  2004-04

Review 6.  Shifts in condom use following microbicide introduction: should we be concerned?

Authors:  Anna M Foss; Peter T Vickerman; Lori Heise; Charlotte H Watts
Journal:  AIDS       Date:  2003-05-23       Impact factor: 4.177

7.  Sex in Australia: autoerotic, esoteric and other sexual practices engaged in by a representative sample of adults.

Authors:  Juliet Richters; Andrew E Grulich; Richard O de Visser; Anthony M A Smith; Chris E Rissel
Journal:  Aust N Z J Public Health       Date:  2003       Impact factor: 2.939

8.  Sex in Australia: heterosexual experience and recent heterosexual encounters among a representative sample of adults.

Authors:  Richard O de Visser; Anthony M A Smith; Chris E Rissel; Juliet Richters; Andrew E Grulich
Journal:  Aust N Z J Public Health       Date:  2003       Impact factor: 2.939

9.  The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.

Authors:  Kathleen Morrow; Rochelle Rosen; Linda Richter; Anne Emans; Anna Forbes; Jennifer Day; Neetha Morar; Lisa Maslankowski; Albert T Profy; Cliff Kelly; Salim S Abdool Karim; Kenneth H Mayer
Journal:  J Womens Health (Larchmt)       Date:  2003-09       Impact factor: 2.681

Review 10.  Recent trends in HIV and other STIs in the United Kingdom: data to the end of 2002.

Authors:  A E Brown; K E Sadler; S E Tomkins; C A McGarrigle; D S LaMontagne; D Goldberg; P A Tookey; B Smyth; D Thomas; G Murphy; J V Parry; B G Evans; O N Gill; F Ncube; K A Fenton
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

View more
  6 in total

1.  Perceptions of reimbursement for clinical trial participation.

Authors:  Carmen Radecki Breitkopf; Melissa Loza; Kathleen Vincent; Thomas Moench; Lawrence R Stanberry; Susan L Rosenthal
Journal:  J Empir Res Hum Res Ethics       Date:  2011-09       Impact factor: 1.742

2.  Contraceptive efficacy, acceptability, and safety of C31G and nonoxynol-9 spermicidal gels: a randomized controlled trial.

Authors:  Anne E Burke; Kurt Barnhart; Jeffrey T Jensen; Mitchell D Creinin; Terri L Walsh; Livia S Wan; Carolyn Westhoff; Michael Thomas; David Archer; Hongsheng Wu; James Liu; William Schlaff; Bruce R Carr; Diana Blithe
Journal:  Obstet Gynecol       Date:  2010-12       Impact factor: 7.661

3.  User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides.

Authors:  Kathleen M Morrow; Kristen Underhill; Jacob J van den Berg; Sara Vargas; Rochelle K Rosen; David F Katz
Journal:  Arch Sex Behav       Date:  2014-01-23

4.  Attitudes towards microbicide use for bacterial vaginosis in pregnancy.

Authors:  Marina Catallozzi; Camille Y Williams; Gregory D Zimet; Katharine M Hargreaves; Shari E Gelber; Adam J Ratner; Lawrence R Stanberry; Susan L Rosenthal
Journal:  Sex Health       Date:  2014-09       Impact factor: 2.706

5.  Relationship context associated with microbicide-like product use.

Authors:  Mary B Short; Susan L Rosenthal; Beth A Auslander; Paul A Succop
Journal:  J Pediatr Adolesc Gynecol       Date:  2009-07-09       Impact factor: 1.814

Review 6.  Dendrimers, an Emerging Opportunity in Personalized Medicine?

Authors:  Anne-Marie Caminade
Journal:  J Pers Med       Date:  2022-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.